2003—2022 年老年人多重用药文献计量学分析

BackgroundIn recent yearsthere has been a noticeable increase in the prevalence of polypharmacy among the older populationleading to a rise in the number of related studies. As a resulta stage analysis of its development is crucial. Objective To analyze the research trends and cutting-edge topics in the field of polypharmacy in the elderly from 2003 to 2022. Methods The Science Citation Index Expanded SCI-E and Social Sciences Citation Index SSCI subsets of the Web of Science Core Collection database were searched for articles and reviews published in English between 2003 and 2022. VOSViewer v.1.6.18 and CiteSpace v.6.1.R6 were used for bibliometric analysis. Results A total of 3 987 articles were obtainedincluding 3 208 articles and 779 reviews. The global volume of publications has increased rapidly in the last 20 yearswith the United States 1 097 articles27.51% having the most publications in this field. The University of Sydney in Australia has been the most prolific institutionpublishing 156 articles 3.91%while Dr. Sarah N. Hilmer of this institution has been the most productive author with 67 publications 1.68%. Among the journalsDrugs & Aging 181 articles4.54% has featured the highest number of publications related to polypharmacy in older people. The high-frequency keywords in the field included elderlypolypharmacyprevalenceand riskwhile the current emerging topics revolved around clinical outcomes and public health issues. Conclusion Over the past two decadesthe field of polypharmacy among older people has experiencedrapid progresscharacterized by an increasing number of publications with the United States as the largest contributor. Research topics have primarily focused on the prevalence and risks associated with polypharmacy among older peoplewhile future studies are expected to focus more on the associated clinical outcomes and public health issues.